source
- Trump administration allocates $50 million to psychedelic research and moves to downgrade medical marijuanaPresident Trump signed an executive order that earmarks $50 million for research into psychedelics as potential mental‑health treatments and directs the FDA to accelerate their review process. The…
- Novartis' Lutathera radioligand therapy may soon face first generic challengerNovartis has built a sizable business delivering radioligand therapies, with Lutathera being a leading product. A rival company is preparing to launch the first generic version, which could introd…